Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
AHRQ releases free evidence-based guides for eight health conditions

AHRQ releases free evidence-based guides for eight health conditions

XARELTO achieves net clinical benefit in treatment of patients with DVT

XARELTO achieves net clinical benefit in treatment of patients with DVT

BRINAVESS IV granted marketing approval in EU for conversion of recent onset AF to sinus rhythm

BRINAVESS IV granted marketing approval in EU for conversion of recent onset AF to sinus rhythm

ESC updates Clinical Practice Guidelines on devices for heart failure treatment

ESC updates Clinical Practice Guidelines on devices for heart failure treatment

ESC announces new Clinical Practice Guidelines on Atrial Fibrillation

ESC announces new Clinical Practice Guidelines on Atrial Fibrillation

ESC issues revised practice guidelines for management of AF

ESC issues revised practice guidelines for management of AF

DANPACE trial shows dual chamber pacing decreases atrial fibrillation in sick sinus syndrome

DANPACE trial shows dual chamber pacing decreases atrial fibrillation in sick sinus syndrome

Phase 3 AVERROES trial reveals apixaban effective for atrial fibrillation patients unsuitable for warfarin

Phase 3 AVERROES trial reveals apixaban effective for atrial fibrillation patients unsuitable for warfarin

Get With The Guidelines can improve quality of stroke care

Get With The Guidelines can improve quality of stroke care

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

Data monitoring committee recommends early termination following impressive results of AVERROES study

Data monitoring committee recommends early termination following impressive results of AVERROES study

Increasing trend seen in hospital admissions due to atrial fibrillation

Increasing trend seen in hospital admissions due to atrial fibrillation

Hospital admissions in Australia due to atrial fibrillation triples

Hospital admissions in Australia due to atrial fibrillation triples

Boehringer Ingelheim announces sub-analysis result of RE-LY trial

Boehringer Ingelheim announces sub-analysis result of RE-LY trial

New research contradicts previous reports on blood-thinner clopidogrel

New research contradicts previous reports on blood-thinner clopidogrel

New campaign to create awareness on atrial fibrillation related strokes

New campaign to create awareness on atrial fibrillation related strokes

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

Preliminary results from Phase 3 AVERROES trial in atrial fibrillation to be presented at cardiology congress 2010

Preliminary results from Phase 3 AVERROES trial in atrial fibrillation to be presented at cardiology congress 2010

ARYx secures bridge financing, reports decrease in net loss to $3.6M for second-quarter 2010

ARYx secures bridge financing, reports decrease in net loss to $3.6M for second-quarter 2010

Study shows early diagnosis of atrial fibrillation reduces risk of stroke

Study shows early diagnosis of atrial fibrillation reduces risk of stroke

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.